Focused Ultrasound Foundation Highlights RebrAIn’s AI Innovations in Neurosurgery
We are excited to share that the Focused Ultrasound Foundation has featured RebrAIn for our pioneering use of artificial intelligence in brain targeting. The article details how our supervised AI-driven platform, Optim MRI, enhances precision and effectiveness in...
L’Usine Digitale Highlights RebrAIn’s €3.7 Million Funding for Supervised AI-Driven Neurosurgery
We are pleased to share that L’Usine Digitale has featured RebrAIn for securing €3.7 million to advance our supervised AI-driven software. This innovative platform is designed to simplify the work of neurosurgeons by enhancing the precision and efficiency of...
La Tribune Features RebrAIn’s €3.7 Million Funding to Aid Neurosurgeons
We are excited to announce that La Tribune has featured RebrAIn for raising €3.7 million. This funding will support the development and commercialization of our supervised AI-driven platform aimed at enhancing Deep Brain Stimulation (DBS) procedures for Parkinson’s...
FrenchWeb Highlights RebrAIn’s €3.7 Million Seed Funding for Parkinson’s Disease Innovation
We are thrilled to share that FrenchWeb has featured RebrAIn for securing €3.7 million in seed funding to advance our AI-driven solutions for treating Parkinson’s Disease. Led by Karista and supported by Nouvelle Aquitaine Co-Investissement, this funding will...
Biotech Finances Highlights RebrAIn’s Successful Funding Round for supervised AI Neurosurgery
We are pleased to announce that Biotech Finances has featured RebrAIn in their recent article. RebrAIn has successfully completed a €3.7 million funding round led by Karista, with participation from Nouvelle Aquitaine Co-Investissement and existing investors. Our...
La Tribune Features RebrAIn’s AI Solutions for Parkinson’s Disease Treatment
We are proud to announce that La Tribune has featured RebrAIn in their recent article discussing the role of AI in treating Parkinson’s Disease. The article and the video highlights our supervised AI-driven platform, developed by Professor Emmanuel Cuny and Dr....
Les Echos Highlights RebrAIn’s AI Innovations in Parkinson’s Disease Treatment
We are thrilled to announce that Les Echos has featured RebrAIn for our innovative application of supervised AI in the treatment of Parkinson’s Disease. The article explores how our AI-driven solutions are revolutionizing Deep Brain Stimulation (DBS) by enhancing...
“La Gazette du Laboratoire” Features RebrAIn’s Breakthrough in Deep Brain Stimulation
We are pleased to announce that La Gazette du Laboratoire has featured RebrAIn for our revolutionary advancements in neurosurgical targeting for Deep Brain Stimulation (DBS). The article highlights our collaboration with SATT Aquitaine Science Transfert and the...